Menu
About Us
Leadership and Executive Team
Our Science
Our Pipeline
Investors
Media & Announcements
The Literature
Glossary of Medical Terms
Contact
Email Alerts
Subscribe to our Email Alerts
Media & Announcements
The Literature
Glossary of Medical Terms
Media & Announcements
12-Aug-2024
Stockhead: Australian biotech pioneer tackling “silver tsunami” of age-related disease
15-Feb-2024
Healthcare Channel: Breakthrough treatment offers hope for elderly blindness
14-Feb-2024
Insight Ophthalmic News: Aussie biotech Filamon commercialising UNSW eye drop for AMD
13-Feb-2024
Filamon to Receive Australian Government Support for Potential Breakthrough Treatment for Blindness in the Elderly
6-Jun-2023
Healthcare Channel: Filamon’s Multiple-Function Drugs: A New Direction in Cancer Therapy
7-Feb-2023
New Aussie Biotech Filamon Aims to Stop Cancer Progressing to a Lethal Disease
31-Jan-2023
Proactive Investors interview “ Filamon Limited on a Mission to Stop the Progression of Cancer”
31-Jan-2023
Second Exclusive Licence Elevates Australian Biotech, Filamon, to a Global Role in New Efforts to Tame Cancer
5-Dec-2022
New Australian biotechnology company aims to block the development of metastatic prostate cancer
1-Dec-2022
Video 1 : Company Introduction to Filamon December 2022
Click here for archives